Your browser doesn't support javascript.
loading
Patch Testing to Chlorhexidine Digluconate, 1% Aqueous: North American Contact Dermatitis Group Experience, 2015-2020.
Warshaw, Erin M; Han, Joohee; Kullberg, Sara A; DeKoven, Joel G; Adler, Brandon L; Silverberg, Jonathan I; Houle, Marie-Claude; Pratt, Melanie D; Belsito, Donald V; Yu, Jiade; Botto, Nina C; Reeder, Margo J; Taylor, James S; Atwater, Amber R; Dunnick, Cory A; DeLeo, Vincent A; Mowad, Chris M.
Affiliation
  • Warshaw EM; From the Department of Dermatology, Park Nicollet Health Services, Minneapolis, Minnesota, USA.
  • Han J; Department of Dermatology, Minneapolis Veterans Affairs Medical Center, Minneapolis, Minnesota, USA.
  • Kullberg SA; Department of Dermatology, University of Minnesota, Minneapolis, Minnesota, USA.
  • DeKoven JG; From the Department of Dermatology, Park Nicollet Health Services, Minneapolis, Minnesota, USA.
  • Adler BL; From the Department of Dermatology, Park Nicollet Health Services, Minneapolis, Minnesota, USA.
  • Silverberg JI; Department of Dermatology, Minneapolis Veterans Affairs Medical Center, Minneapolis, Minnesota, USA.
  • Houle MC; University of Minnesota Medical School, Minneapolis, Minnesota, USA.
  • Pratt MD; Division of Dermatology, Sunnybrook Health Sciences Centre, University of Toronto, Ontario, Canada.
  • Belsito DV; Department of Dermatology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
  • Yu J; Department of Dermatology, The George Washington University School of Medicine and Health Sciences, Washington, District of Columbia, USA.
  • Botto NC; Division of Dermatology, CHU de Quebec, Laval University, Quebec City, Quebec, Canada.
  • Reeder MJ; Division of Dermatology, University of Ottawa, Ottawa, Ontario, Canada.
  • Taylor JS; Department of Dermatology, Columbia University Irving Medical School, New York, New York, USA.
  • Atwater AR; Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Dunnick CA; Department of Dermatology, University of California, San Francisco, California, USA.
  • DeLeo VA; Department of Dermatology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
  • Mowad CM; Department of Dermatology, Cleveland Clinic, Cleveland, Ohio, USA.
Dermatitis ; 34(6): 501-508, 2023.
Article de En | MEDLINE | ID: mdl-37279017
ABSTRACT

Background:

Chlorhexidine is an antiseptic that may cause allergic contact dermatitis.

Objectives:

To describe the epidemiology of chlorhexidine allergy and characterize positive patch test reactions.

Methods:

This retrospective study analyzed patients patch tested to chlorhexidine digluconate 1% aqueous by the North American Contact Dermatitis Group, 2015-2020.

Results:

Of 14,731 patients tested to chlorhexidine digluconate, 107 (0.7%) had an allergic reaction; of these, 56 (52.3%) reactions were currently clinically relevant. Most (59%) reactions were mild (+), followed by strong (++, 18.7%) and very strong (+++, 6.5%). Common primary dermatitis anatomic sites in chlorhexidine-positive patients were hands (26.4%), face (24.5%), and scattered/generalized distribution (17.9%). Compared with negative patients, chlorhexidine-positive patients were significantly more likely to have dermatitis involving the trunk (11.3% vs 5.1%; P = 0.0036). The most commonly identified source category was skin/health care products (n = 41, 38.3%). Only 11 (10.3%) chlorhexidine reactions were occupationally related; of these, 81.8% were in health care workers.

Conclusions:

Chlorhexidine digluconate allergy is uncommon, but often clinically relevant. Involvement of the hands, face, and scattered generalized patterns was frequent. Occupationally related reactions were found predominantly in health care workers.
Sujet(s)

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Eczéma de contact allergique / Dermatite professionnelle Type d'étude: Observational_studies Limites: Humans Pays/Région comme sujet: America do norte Langue: En Journal: Dermatitis Sujet du journal: DERMATOLOGIA Année: 2023 Type de document: Article Pays d'affiliation: États-Unis d'Amérique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Eczéma de contact allergique / Dermatite professionnelle Type d'étude: Observational_studies Limites: Humans Pays/Région comme sujet: America do norte Langue: En Journal: Dermatitis Sujet du journal: DERMATOLOGIA Année: 2023 Type de document: Article Pays d'affiliation: États-Unis d'Amérique